These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 14704115)
1. Advances in modeling of biomolecular interactions. Cai CZ; Li ZR; Wang WL; Chen YZ Acta Pharmacol Sin; 2004 Jan; 25(1):1-8. PubMed ID: 14704115 [TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of hydration in drug design. Mancera RL Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853 [TBL] [Abstract][Full Text] [Related]
3. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
4. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development. Rajamani R; Good AC Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857 [TBL] [Abstract][Full Text] [Related]
5. Lead optimization via high-throughput molecular docking. Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852 [TBL] [Abstract][Full Text] [Related]
7. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics. Cohen C; Fischel O; Cohen E Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460 [TBL] [Abstract][Full Text] [Related]
8. The use of protein-ligand interaction fingerprints in docking. Brewerton SC Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089 [TBL] [Abstract][Full Text] [Related]
9. Molecular simulation and drug design. Lybrand TP J Pharm Belg; 1991; 46(1):49-54. PubMed ID: 2051301 [TBL] [Abstract][Full Text] [Related]
10. Consensus scoring for protein-ligand interactions. Feher M Drug Discov Today; 2006 May; 11(9-10):421-8. PubMed ID: 16635804 [TBL] [Abstract][Full Text] [Related]
11. Computer-based design of novel protein structures. Butterfoss GL; Kuhlman B Annu Rev Biophys Biomol Struct; 2006; 35():49-65. PubMed ID: 16689627 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics and cheminformatics: where do the twain meet? Sukumar N; Krein M; Breneman CM Curr Opin Drug Discov Devel; 2008 May; 11(3):311-9. PubMed ID: 18428084 [TBL] [Abstract][Full Text] [Related]
13. 2D molecular graphics: a flattened world of chemistry and biology. Zhou P; Shang Z Brief Bioinform; 2009 May; 10(3):247-58. PubMed ID: 19332474 [TBL] [Abstract][Full Text] [Related]
15. Biomolecular modeling: Goals, problems, perspectives. van Gunsteren WF; Bakowies D; Baron R; Chandrasekhar I; Christen M; Daura X; Gee P; Geerke DP; Glättli A; Hünenberger PH; Kastenholz MA; Oostenbrink C; Schenk M; Trzesniak D; van der Vegt NF; Yu HB Angew Chem Int Ed Engl; 2006 Jun; 45(25):4064-92. PubMed ID: 16761306 [TBL] [Abstract][Full Text] [Related]
16. Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Wolber G; Seidel T; Bendix F; Langer T Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860 [TBL] [Abstract][Full Text] [Related]
17. Informatics and modeling challenges in fragment-based drug discovery. Hubbard RE; Chen I; Davis B Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855 [TBL] [Abstract][Full Text] [Related]
18. Haptic-driven applications to molecular modeling: state-of-the-art and perspectives. Ricci A; Anthopoulos A; Massarotti A; Grimstead I; Brancale A Future Med Chem; 2012 Jun; 4(10):1219-28. PubMed ID: 22800367 [TBL] [Abstract][Full Text] [Related]
19. Combining structure-based drug design and pharmacophores. Griffith R; Luu TT; Garner J; Keller PA J Mol Graph Model; 2005 Apr; 23(5):439-46. PubMed ID: 15781186 [TBL] [Abstract][Full Text] [Related]